Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer

ANZ Journal of Surgery

Volumn 75, Issue 5, 2005, Pages 286-291

  Chao, Michael ^a,c   Gibbs, Peter ^a   Tjandra, Joe ^a   Cullinan, Mark ^a   McLaughlin, Stephen ^b   Faragher, Ian ^b   Skinner, Iain ^b   Jones, Ian ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b WESTERN HOSPITAL   (Australia)

^c NONE   (Australia)

Author keywords

Chemotherapy; Preoperative; Radiotherapy; Rectal cancer; Surgery

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; ADVANCED CANCER; ANUS SPHINCTER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DIARRHEA; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MINIMAL RESIDUAL DISEASE; MORTALITY; NAUSEA; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; RADIATION DOSE DISTRIBUTION; RECTUM CANCER; TREATMENT OUTCOME;

ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 20444503409     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2005.03348.x     Document Type: Article

References (29)

1. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 2001; 345: 638-46.
2. No authors listed. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N. Engl. J. Med. 1997; 336: 980-7.
3. Minsky BD. Adjuvant therapy for rectal cancer-a good first step. N. Engl. J. Med. 1997; 336: 1016-17.
4. Byfield JE, Calabro-Jones P, Klisak I, Kulhanian F. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-Fluorouracil or ftorafur and X rays. Int. J. Radiat. Oncol. Biol. Phys. 1982; 8: 1923-33.
5. Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks G. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int. J. Radiat. Oncol. Biol. Phys. 1994; 30: 169-75.
6. Minsky BD, Cohen AM, Kemeny N et al. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy. J. Clin. Oncol. 1992; 10: 79-84.
7. Kelsen DP, Hilaris B, Martini N. Neoadjuvant chemotherapy and surgery of cancer of the esophagus. Semin. Surg. Oncol. 1986; 2: 170-6.
8. Radiation Therapy Oncology Group. Acute Radiation Morbidity Scoring Criteria [Internet]. Philadelphia: Radiation Therapy Oncology Group; [cited 11 February 2005]. Available from: http://www.rtog.org/members/toxicity/acute.html.
9. Gelman R, Gelber R, Henderson IC, Coleman CN, Harris JR. Improved methodology for analyzing local and distant recurrence. J. Clin. Oncol. 1990; 8: 548-55.
10. Janjan NA, Abbruzzese J, Pazdur R et al. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother. Oncol. 1999; 51: 153-60.
11. Theodoropoulos G, Wise WE, Padmanabhan A et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis. Colon Rectum 2002; 45: 895-903.
12. Mohiuddin M, Hayne M, Regine WF et al. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int. J. Radiat. Oncol. Biol. Phys. 2000; 48: 1075-80.
13. Luna-Perez P, Rodriguez-Ramirez S, Rodriguez-Coria DF et al. Preoperative chemoradiation therapy and anal sphincter preservation with locally advanced rectal adenocarcinoma. World J. Surg. 2001; 25: 1006-11.
14. Mehta VK, Poen J, Ford J et al. Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer. Dis. Colon Rectum 2001; 44: 52-8.
15. Janjan NA, Khoo VS, Rich TA et al. Locally advanced rectal cancer: surgical complications after infusional chemotherapy and radiation therapy. Radiology 1998; 206: 131-6.
16. Paty PB, Enker WE, Cohen AM, Lauwers GY. Treatment of rectal cancer by low anterior resection with coloanal anastomosis. Ann. Surg. 1994; 219: 365-73.
17. Shirouzu K, Isomoto H, Kakegawa T. Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer 1995; 76: 388-92.
18. Kuvshinoff B, Maghfoor I, Miedema B et al. Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are < or = 1 cm distal margins sufficient? Ann. Surg. Oncol. 2001; 8: 163-9.
19. Karanjia ND, Schache DJ, North WR, Heald RJ. 'Close shave' in anterior resection. Br. J. Surg. 1990; 77: 510-12.
20. Nakagawa WT, Rossi BM, de O Ferreira F et al. Chemoradiation instead of surgery to treat mid and low rectal tumors: is it safe? Ann. Surg. Oncol. 2002; 9: 568-73.
21. Marijnen CA, Kapiteijn E, van de Velde CJ et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J. Clin. Oncol. 2002; 20: 817-25.
22. Tjandra JJ, Reading DM, McLachlan SA et al. Phase II clinical trial of preoperative combined Chemoradiation for T3 and T4 resectable rectal cancer: preliminary results. Dis. Colon Rectum 2001; 44: 1113-22.
23. Ngan SY, Burmeister BH, Fisher R et al. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 2001; 50: 883-7.
24. Onaitis MW, Noone RB, Hartwig M et al. Neoadjuvant chemoradiation for rectal cancer: analysis of clinical outcomes from a 13-year institutional experience. Ann. Surg. 2001; 233: 778-85.
25. Pucciarelli S, Friso ML, Toppan P et al. Preoperative combined radiotherapy and chemotherapy for middle and lower rectal cancer: preliminary results. Ann. Surg. Oncol. 2000; 7: 38-44.
26. Reynolds JV, Joyce WP, Dolan J, Sheahan K, Hyland JM. Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br. J. Surg. 1996; 83: 1112-15.
27. Vauthey JN, Marsh RW, Zlotecki RA et al. Recent advances in the treatment and outcome of locally advanced rectal cancer. Ann. Surg. 1999; 229: 745-52.
28. Fisher B, Wolmark N, Rockette H et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J. Natl Cancer Inst. 1988; 80: 21-9.
29. Sauer R. Adjuvant versus neoadjuvant combined modality treatment for locally advanced rectal cancer: first results of the German rectal cancer study (CAO/ARO/AIO-94). Int. J. Radiat. Oncol. Biol. Phys. 2003; 57: S124-5.